This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
iot: Archive
Is Qualcomm Stock a Smart Buy Before Q3 Earnings Release?
by Arijit Sarkar
QCOM is set to report Q3 results with new Snapdragon launches boosting AI, PCs and smartphones, but competition and Android demand remain key challenges.
QCOMNegative Net Change INTCNegative Net Change AVGONegative Net Change
computers earnings-preview iot mobile semiconductor tech-stocks
How AT&T Uses Fiber, 5G and Edge Demand to Build 2026 Growth Momentum
by Supriyo Bose
T is building 2026 momentum through fiber convergence, 5G reach, edge demand and Open RAN savings, while competition and capital needs remain checks.
TNegative Net Change VZNegative Net Change TMUSNegative Net Change
communications iot mobile tech-stocks telecom
Is T Stock Attractive After Earnings Beats and Discounted Valuation
by Supriyo Bose
T's earnings beat, rising free cash flow and low valuation strengthen its value case, but debt, heavy spending and uneven growth temper the outlook.
TNegative Net Change VZNegative Net Change TMUSNegative Net Change
artificial-intelligence communications iot mobile tech-stocks telecom
AT&T Stock Outlook Hinges on Fiber Growth and Wireless Risks in 2026
by Supriyo Bose
T's 2026 outlook rests on fiber, 5G and bundled growth, but wireless promotions, legacy declines and heavy investment keep risks elevated.
TNegative Net Change VZNegative Net Change TMUSNegative Net Change
communications iot mobile tech-stocks telecom
Iridium Q2 Earnings Lag, Sales Up Y/Y, Rocket Lab Acquisition in Focus
by Zacks Equity Research
IRDM's revenue beat estimates as new satellite products, Aireon and Rocket Lab deals reshape its growth strategy despite an EPS miss.
IRDMPositive Net Change ERICNegative Net Change AMXNegative Net Change BBNegative Net Change RKLBNegative Net Change
aerospace business-services communications earnings iot mobile tech-stocks
IBM Q2 Earnings Meet Estimates, Revenue Misses on Deal Delays
by Zacks Equity Research
IBM's Q2 earnings met estimates, but delayed software deals and weaker mainframe sales drove a revenue miss and lower 2026 growth guidance.
IBMPositive Net Change AKAMNegative Net Change ANETPositive Net Change PINSNegative Net Change
artificial-intelligence cloud-computing computers earnings iot saas tech-stocks
Sky Harbour Group Corporation (SKYH) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
SKYHNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Home BancShares (HOMB)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
HOMBNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Aveanna Healthcare (AVAH) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
AVAHNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
KE Focuses on Holistic Growth for Sustainability: Reason to Buy?
by Supriyo Bose
Kimball is investing in medical manufacturing, automation and acquisitions to support higher margins and sustainable long-term growth.
KENegative Net Change FLEXPositive Net Change MKSINegative Net Change
iot tech-stocks